Bristol-Myers Squibb
BMY
#197
Rank
โ‚น11.031 T
Marketcap
โ‚น5,402
Share price
0.67%
Change (1 day)
45.17%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2026 (TTM): โ‚น4.333 Trillion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is โ‚น4.613 Trillion. In 2025 the company made a revenue of โ‚น4.326 Trillion an increase over the revenue in the year 2024 that were of โ‚น4.143 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น4.333 T0.17%
2025 โ‚น4.326 T4.42%
2024 โ‚น4.143 T10.59%
2023 โ‚น3.746 T-1.91%
2022 โ‚น3.819 T10.63%
2021 โ‚น3.452 T11.03%
2020 โ‚น3.109 T66.78%
2019 โ‚น1.864 T18.19%
2018 โ‚น1.577 T18.92%
2017 โ‚น1.326 T0.49%
2016 โ‚น1.320 T19.96%
2015 โ‚น1.100 T9.35%
2014 โ‚น1.006 T-0.58%
2013 โ‚น1.012 T4.92%
2012 โ‚น964.80 B-14.15%
2011 โ‚น1.123 T28.72%
2010 โ‚น873.07 B12.69%
2009 โ‚น774.74 B-21.74%
2008 โ‚น989.99 B37.98%
2007 โ‚น717.51 B-9.57%
2006 โ‚น793.41 B-8.2%
2005 โ‚น864.31 B13.62%
2004 โ‚น760.70 B-20.53%
2003 โ‚น957.17 B10.16%
2002 โ‚น868.88 B-6.11%
2001 โ‚น925.46 B3.96%
2000 โ‚น890.17 B5.7%
1999 โ‚น842.15 B8.32%
1998 โ‚น777.43 B18.45%
1997 โ‚น656.34 B21.19%
1996 โ‚น541.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.169 T 98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.383 T 16.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.024 T 30.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น5.819 T 26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.875 T 49.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.541 T-23.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.277 T 14.39%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น945.61 B-79.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.258 T 35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.751 T 24.66%๐Ÿ‡ฌ๐Ÿ‡ง UK